Clinical Trials Update: Apr. 4, 2003
Ovarian Cancer HIV Vaccines
(HealthDayNews) -- Here are the latest clinical trials, courtesy of CenterWatch:
A phase III clinical trial of an investigational medication for late stage ovarian cancer, following primary therapy. Research sites located throughout the United States.
A phase I/II study to examine the safety of an investigational medication in patients with HIV who are receiving highly active antiretroviral therapy (HAART). The study will also determine the highest dose of the drug that can be given without causing serious side effects. Patients with HIV who are 18 years of age and older may be eligible. Research site located in Bethesda, Maryland.
A trial to assess whether a new vaccine is safe and effective for prevention of genital herpes symptoms. Women between ages 18 and 30, who are sexually active or plan to be over the next year, and are not infected with herpes, may be eligible. Research site located in Denver, Colorado.
Copyright 2003 CenterWatch. All rights reserved.